anonymous
Guest
anonymous
Guest
BINGO! The faith has left the stadium!
BINGO! The faith has left the stadium!
The drug could have had substantially higher sales if Frost was not so greedy. And it would have made the patient transition to the dialysis indication immensely easier. But when you have an 85 year old at the helm and the head of the division in his mid seventies, long term planning is not in the cards.
Working hard to give more drug away to hasten the inevitable collapse of OPKO Renal. Makes total sense.
Baggage! This division is doomed.
Oh no, someone call a Wammmbulance for all the moaners on this board. Maybe you people should try your hand in the adult film industry. I heard they are in need of some good fluffers.
Yep. As covid testing demand goes down, the stock will return to $1.50. Nothing here folks.
When the margin dollars were built on the false premise of funding by the 501c3 funds and now are lost, is that the fault of the reps? You don’t want to pay a bonus? Fine, we will vote with our feet and leave. The only reason you would not pay would be if you had no faith in the future of Rayaldee.
Tired of the nonsense? How long can this charade play out?
The majority of the salesforce doesn’t have a shot at making a bonus. Patty thinks that we can continue emailing our customers. Our customers don’t care.
Baggage! This division is doomed.
This division was yet another business venture for the Ivory Tower to capitalize on, even at the expense of people’s livelihoods.
No, but I have yours.
Tired of the nonsense? How long can this charade play out?
The majority of the salesforce doesn’t have a shot at making a bonus. Patty thinks that we can continue emailing our customers. Our customers don’t care.
Oh no, someone call a Wammmbulance for all the moaners on this board. Maybe you people should try your hand in the adult film industry. I heard they are in need of some good fluffers.
Tired of the nonsense? How long can this charade play out?
The majority of the salesforce doesn’t have a shot at making a bonus. Patty thinks that we can continue emailing our customers. Our customers don’t care.
Nature of the beast, my friend.
Famous quote, “What the hell do you think we’re doing, ya moron?
DOA!
What are you waiting for? No miracles at OPKO? You have nothing to lose. How do you propose that we make sure that Frost and the board know what is really going happening on the ground?
The issue is the questionable number of CKD 3 and CKD 4 patients. The Data that the so called Analyst gurus looked at is all encompassing. It was not filtered out by SHPT. So, when you see all of the active vitamin D, you can pretty much bet it is CKD5 at Fresenius.
And because the HCP’s are prescribing for CKD 5 for SHPT it skews the “opportunity”.
The powers in the towers will tell you otherwise; however, ask you docs that are affiliated with Fresenius. They will tell you that they are using oral calictriol instead of IV.
When the margin dollars were built on the false premise of funding by the 501c3 funds and now are lost, is that the fault of the reps? You don’t want to pay a bonus? Fine, we will vote with our feet and leave. The only reason you would not pay would be if you had no faith in the future of Rayaldee.
“ Due mainly to the decline in sales of Rayaldee amid Covid-19 impact, the pharma revenue has dropped approximately 3.8% YoY in the quarter despite an approximate YoY growth for the year”
Sounds fishy...
As Q4 Covid-19 testing volume rose 24%, diagnostics the largest contributor to revenue.
So, If Rayaldee sales were down due to COVID-19, and revenue sales were up 24% due to COVID-19, read between the lines that 501c3 funding has had a significant impact on pharma revenue.
Not to mention that patients that have a greater than 30 no/ml 25OHD level are benefiting/ dodging the virus.
Nice job, CB! Way to smooth out the numbers!